Bell Investment Advisors, Inc Summit Therapeutics Inc. Transaction History
Bell Investment Advisors, Inc
- $533 Million
- Q4 2024
A detailed history of Bell Investment Advisors, Inc transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 66 shares of SMMT stock, worth $1,263. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66Holding current value
$1,263% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
233Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$468 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$223 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$151 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$126 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$107 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.85B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...